In-Person Access Only | 7.25 CE/CME Credits & MOC Points
All programs remain free. Registrations will require a credit card as a cancellation hold. A fee of $99 will only be incurred in the event of a no-show or cancellation within 5 days without written confirmation to the Total Health Program Team.
Total Health's 2025 ASCO Direct™ Austin Conference is an officially licensed ASCO Direct meeting. This Post ASCO Review showcases abstracts from highly rated presentations, allowing attendees to engage with the latest research and strategies in oncology education. This accredited meeting will be hosted as an in-person conference only with on-demand access for registered attendees.
Conference Agenda
Saturday, June 21, 2025
8:00 AM
Coffee and Exhibits
8:30 AM
Program Chair Welcome
8:40 AM
Colorectal Cancer
Sarbajit Mukherjee, MD | Miami Cancer Institute
9:10 AM
Non-Colorectal Cancer
Kyaw Aung, MD, PhD | UT Health Austin
9:40 AM
Breakfast and Exhibits
9:55 AM
Non-CME Breakfast - Stemline - Orserdu elacestrant - For patients with ER+/HER2- ESR1-mutated mBC, upon progression on 1L ET + CDK4/6i
Martin Dietrich, MD | University of Central Florida College of Medicine
10:40 AM
Prostate Cancer
Qian [Janie] Qin, MD | UT Southwestern Medical Center | UT Southwestern Medical Center
11:10 AM
Non-Prostate Cancer
Mike Lattanzi, MD | Texas Oncology
11:40 AM
Lunch and Exhibits
11:55 AM
Non-CME Lunch - Pfizer - Clinical Case Reviews: Treatment of a Broad Range of Patients With HR+/HER2- Metastatic Breast Cancer
Vandana G Abramson, MD, MTR | Vanderbilt University
12:40 PM
Housekeeping and Survey
12:50 PM
Leukemia
Tapan Kadia, MD | MD Anderson
1:20 PM
Lymphoma
Luis Fayad, MD | MD Anderson
1:50 PM
Multiple Myeloma
Larry Anderson, MD | UT Southwestern Medical Center
2:20 PM
Melanoma
Isabella Glitza Oliva, MD, PhD | University of Texas MD Anderson Cancer Center
2:50 PM
Networking Reception
3:50 PM
Adjourn
Sunday, June 22, 2025
8:00 AM
Coffee and Exhibits
8:30 AM
Program Chair Welcome
8:40 AM
Small Cell Lung Cancer
Erminia Massarelli, MD, PhD, MS | UT Health East Texas
9:10 AM
Non-Small Cell Lung Cancer
Laura Chow, MD | Texas Oncology
9:40 AM
Breakfast and Exhibits
9:55 AM
Non-CME Breakfast - Gilead - Offering an ADC Treatment for Patients With Pretreated HR+/HER2- mBC and mTNBC
Marcela Mazo Canola, MD | Mays Cancer Center, University of Texas Health at San Antonio
10:40 AM
Head and Neck Cancer
Neal Akhave, MD | University of Texas MD Anderson Cancer Center
11:10 AM
Sarcomas and Rare Cancers
Lauren Banks, MD | Memorial Sloan Kettering Cancer Center
11:40 AM
Lunch and Exhibits
11:55 AM
Non-CME Lunch - Incyte Pemazyre - PEMAZYRE: The First FDA-Approved Treatment for Adults With Previously Treated, Unresectable, Locally Advanced or Metastatic Cholangiocarcinoma With an FGFR2 Fusion or Other Rearrangement as Detected by an FDA-Approved Test
Erin Schwab, MD, MPH | Vail Health Shaw Cancer Center
12:40 PM
Early-Stage Breast Cancer
Heather McArthur, MD | UT Southwestern Medical Center
1:10 PM
Metastatic Breast Cancer
Elyse Lower, MD | University of Cincinnati
1:40 PM
Survivorship
Sasha Davis, MD | Texas Oncology
2:10 PM
Adjourn
Agenda Subject To Change. All times are CST.
-
Integrate new evidence into everyday clinical practice, thereby improving the quality of care being delivered to patients living with and beyond cancer.
Implement practice changes in a variety of treatment options for solid tumors, including lung, breast, melanoma, colorectal, non-colorectal GI, and GU cancers
Stimulate innovative strategies for new and additional research related to treatment and prevention
Recognize the implications for practice change in both the academic and community practice settings
-
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Total Health. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Nurses (ANCC) Credit Designation
Amedco LLC designates this activity for a maximum of 7.25 ANCC contact hours.
Physicians (ACCME) Credit Designation
Amedco LLC designates this live activity for a maximum of 7.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Pharmacists and Pharmacy Technicians (ACPE) Credit Designation
Amedco LLC designates this activity for a maximum of 7.25 knowledge-based CPE contact hours.
NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 30 days of your participation in the activity to meet the deadline for submission to CPE Monitor.
American Board of Internal Medicine (ABIM) MOC Credit
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 7.25 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. You must request your certificate within 30 days of the activity to meet the deadline for submission to PARS.
-
Free registration for all healthcare providers
Expert sessions that present the most clinically relevant data, research, and clinical strategies
Enduring video content for watching at your leisure
Real-time discussion and debate
Networking with peers, colleagues, and medical professionals
Access to the latest industry information and resources
Catered meals through-out the program